from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1573/-

LFCtreatmentdescriptionclass of inhibitor

-0.149

Amikacinug/mL Amikacintranslation

0.034

Cap5-10ug/mL Capreomycintranslation

0.501

Rox10-50 ug/mL Roxithromycintranslation

-0.402

SM2-5 ug/mL Streptomycintranslation

-0.133

Tet5-10 ug/mL Tetracyclinetranslation

0.556

Rif0.2-5ug/mL Rifampicintranscription

-0.604

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.574

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.257

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.657

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.600

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.503

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.495

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.461

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.270

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.520

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.096

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.003

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.498

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.184

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.144

KCN5-20 ug/mL Potassium cyaniderespiration

0.279

NaN30.2-2 mM Sodium aziderespiration

-0.017

Nigericin50 uM Nigericinrespiration

0.475

TRC10-150 ug/mL Triclosanrespiration

-1.116

TRZ10-25 ug/mL Thioridazinerespiration

0.385

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.117

menadione6-10 ug/mL Menadionerespiration

-0.065

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.483

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.178

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.231

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.021

NRP_1Non-replicating persistence stage 1dosRassociated

-0.813

Amp0.2mg/mL AmpicillincellWall

-0.388

Cephalexin20-100 ug/mL CephalexincellWall

0.414

Cerulenin0.32-5 ug/mL CerulenincellWall

0.187

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.758

EMB10-20 ug/mL EthambutolcellWall

-0.627

Eta12-40 ug/mL EthionamidecellWall

-0.842

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.134

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.025

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.106

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.376

BZA0.12 mg/mL BenzamidearomaticAmides

0.537

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.123

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.096

H2O24 mM hydrogen peroxideDNAdamaging

0.215

Levo10 ug/mL LevofloxacinDNAdamaging

-0.530

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.356

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.236

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.083

UVUV-irradiationDNAdamaging

0.415

ARP41-4 ug/mL Antitubercular compound ARP4?

0.071

Antimycin12.5-50 ug/mL Antimycin A?

0.023

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.040

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.129

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.482

PA8240.2-2 ug/mL PA-824?

-0.412

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.168

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.426

Verapamil50 uM Verapamil?

0.113

mercaptoethanol2 mM 2-Mercaptoethanol?

0.066

methoxatin10-20 ug/mL Methoxatin?